CN102482664A - 用于预测c型肝炎的治疗效果的标记物和预测c型肝炎的治疗效果的方法以及c型肝炎的预防或治疗剂 - Google Patents

用于预测c型肝炎的治疗效果的标记物和预测c型肝炎的治疗效果的方法以及c型肝炎的预防或治疗剂 Download PDF

Info

Publication number
CN102482664A
CN102482664A CN2010800365956A CN201080036595A CN102482664A CN 102482664 A CN102482664 A CN 102482664A CN 2010800365956 A CN2010800365956 A CN 2010800365956A CN 201080036595 A CN201080036595 A CN 201080036595A CN 102482664 A CN102482664 A CN 102482664A
Authority
CN
China
Prior art keywords
hepatitis
therapeutic effect
polynucleotide
oligonucleotide
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800365956A
Other languages
English (en)
Chinese (zh)
Inventor
田中靖人
沟上雅史
德永胜士
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Health Sciences Foundation
Nagoya City University
Original Assignee
Japan Health Sciences Foundation
Nagoya City University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Health Sciences Foundation, Nagoya City University filed Critical Japan Health Sciences Foundation
Publication of CN102482664A publication Critical patent/CN102482664A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2010800365956A 2009-08-21 2010-08-05 用于预测c型肝炎的治疗效果的标记物和预测c型肝炎的治疗效果的方法以及c型肝炎的预防或治疗剂 Pending CN102482664A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009-192615 2009-08-21
JP2009192615A JP5727694B2 (ja) 2009-08-21 2009-08-21 Ｃ型肝炎の治療効果を予測するためのマーカー及びｃ型肝炎の治療効果の予測を行う方法並びにｃ型肝炎の予防又は治療剤
PCT/JP2010/063262 WO2011021508A1 (ja) 2009-08-21 2010-08-05 Ｃ型肝炎の治療効果を予測するためのマーカー及びｃ型肝炎の治療効果の予測を行う方法並びにｃ型肝炎の予防又は治療剤

Publications (1)

Publication Number Publication Date
CN102482664A true CN102482664A (zh) 2012-05-30

Family

ID=43606963

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800365956A Pending CN102482664A (zh) 2009-08-21 2010-08-05 用于预测c型肝炎的治疗效果的标记物和预测c型肝炎的治疗效果的方法以及c型肝炎的预防或治疗剂

Country Status (3)

Country Link
JP (1) JP5727694B2 (enExample)
CN (1) CN102482664A (enExample)
WO (1) WO2011021508A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102816838A (zh) * 2012-07-06 2012-12-12 吉林艾迪康医学检验所有限公司 用于检测丙型肝炎患者il28b snp12980275多态性的试剂盒

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5656159B2 (ja) * 2009-08-24 2015-01-21 独立行政法人理化学研究所 インターフェロン療法の効果予測用マーカー
JP5787337B2 (ja) * 2010-03-19 2015-09-30 公益財団法人ヒューマンサイエンス振興財団 Ｃ型肝炎の治療効果を予測するためのマーカー群、検査方法及び検査用キット
EP2691094A1 (en) * 2011-03-31 2014-02-05 Novartis AG Alisporivir to treat hepatitis c virus infection
CN103074417B (zh) * 2012-06-20 2015-06-24 宁波海尔施基因科技有限公司 一种丙型肝炎治疗用药指导的多重基因检测方法
US20160053309A1 (en) 2013-03-26 2016-02-25 Nippon Gene Co., Ltd. Set of primers and probes to be used for identification of gene polymorphism and use thereof
JP6155750B2 (ja) * 2013-03-27 2017-07-05 東洋紡株式会社 ＳＮＰ（ｒｓ１１８８１２２２）を検出するためのプローブ

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DONGLIANG GE ET AL.: "Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance", 《NATURE》 *
NAZIA SELZNER IAN MCGILVRAY: "Can genetic variations predict HCV treatment outcomes?", 《JOURNAL OF HEPATOLOGY》 *
TIMOTHY R. MORGAN ET AL.: "DNA polymorphisms and response to treatment in patients with chronic hepatitis C：results from the HALT-C trial", 《JOURNAL OF HEPATOLOGY》 *
YASUHITO TANAKA ET AL.: "Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C", 《NATURE GENETICS》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102816838A (zh) * 2012-07-06 2012-12-12 吉林艾迪康医学检验所有限公司 用于检测丙型肝炎患者il28b snp12980275多态性的试剂盒

Also Published As

Publication number Publication date
JP5727694B2 (ja) 2015-06-03
WO2011021508A1 (ja) 2011-02-24
JP2011041526A (ja) 2011-03-03

Similar Documents

Publication Publication Date Title
CN102482664A (zh) 用于预测c型肝炎的治疗效果的标记物和预测c型肝炎的治疗效果的方法以及c型肝炎的预防或治疗剂
CN104630374A (zh) 与类风湿关节炎相关的单个基因单核苷酸多态性位点及其应用
CA2460215A1 (en) Haplotype map of the human genome and uses therefor
CN109504763A (zh) 用于预测α干扰素治疗乙肝患者疗效的分子标记
CN114921542A (zh) 一种与病毒性肝炎抗病毒治疗应答预测相关的snp分子标记及其应用
JP4295955B2 (ja) インターフェロンαレセプター２型遺伝子の多型およびその使用
KR101100437B1 (ko) 단일염기 다형을 포함하는 대장암과 관련된 폴리뉴클레오티드, 그를 포함하는 마이크로어레이 및 진단 키트 및 그를 이용한 대장암의 진단방법
CN117844916A (zh) 识别阿尔茨海默病高危人群的多基因遗传风险分数模型
JP5787337B2 (ja) Ｃ型肝炎の治療効果を予測するためのマーカー群、検査方法及び検査用キット
JP4197623B2 (ja) インターフェロンの治療効果を予測するための新規多型マーカー、プライマー、プローブおよびインターフェロンの治療効果を予測する方法
CN103882112B (zh) 一种预测强直性脊柱炎易感性的试剂及方法
CN103060330B (zh) 一种预测前列腺癌易感性的试剂盒
CN110592236B (zh) TNFSF11基因rs9525641 SNP的应用
JP6245796B2 (ja) 原発性胆汁性肝硬変の発症リスク予測マーカー、プローブ、プライマー及びキット並びに原発性胆汁性肝硬変の発症リスク予測方法
CN110484658B (zh) TNFRSF13B基因rs34562254 SNP的应用
KR100695147B1 (ko) 다중좌 마커를 이용한 2형 당뇨병의 진단방법, 2형당뇨병과 연관된 마커를 포함하는 폴리뉴클레오티드 및마이크로어레이
CN103695549A (zh) 预测强直性脊柱炎易感性的试剂
CN103060329B (zh) 一种预测前列腺癌易感性的检测试剂和方法
CN103060433B (zh) 一种预测前列腺癌易感性的试剂盒和方法
KR101071081B1 (ko) Ｄｅｆａ4 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 이를 이용한 검출 방법
KR20130100640A (ko) 복부비만 예측용 ｓｎｐ 마커 및 이의 용도
JP5070552B2 (ja) Ｃ型慢性肝炎治療効果予測のための検査方法及び検査用キット
KR100803258B1 (ko) 단일염기다형을 포함하는 폴리뉴클레오티드, 그를 포함하는마이크로어레이 및 진단키트, 그를 이용한 ｂ형 간염백신에 대한 항체-무반응 진단방법
CN103710446B (zh) 预测强直性脊柱炎易感性的试剂和方法
Chai et al. Genetic polymorphisms and periodontitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120530